CNSP - Company ID 0001729427
CNS Pharmaceuticals, Inc. has filed 379 public company documents between 2018 and 2026. The most frequent type is major company event (98 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| EFFECT | EFFECT | 5mo ago2026-05-26 | - | View filing |
| 424B3 | 424B3 | 5mo ago2026-05-26 | - | View filing |
| 4 | Insider trade | 5mo ago2026-05-20 | 2026-05-18 | View filing |
| D | D | 5mo ago2026-05-19 | - | View filing |
| S-3 | Securities registration | 5mo ago2026-05-19 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 5mo ago2026-05-15 | - | View filing |
| 10-Q | Quarterly report | 5mo ago2026-05-14 | 2026-03-31 | View filing |
| 8-K | Major company event | 6mo ago2026-05-04 | 2026-05-04 | View filing |
| 10-K/A | Annual report (amended) | 6mo ago2026-04-30 | 2025-12-31 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 6mo ago2026-04-17 | - | View filing |
| 10-K | Annual report | 7mo ago2026-03-31 | 2025-12-31 | View filing |
| 8-K | Major company event | 8mo ago2026-03-11 | 2026-03-11 | View filing |
| 4 | Insider trade | 8mo ago2026-03-04 | 2026-03-02 | View filing |
| 3 | New insider ownership | 8mo ago2026-03-04 | 2026-03-02 | View filing |
| 4 | Insider trade | 8mo ago2026-03-04 | 2026-03-02 | View filing |
| 3 | New insider ownership | 8mo ago2026-03-04 | 2026-03-02 | View filing |
| 8-K | Major company event | 8mo ago2026-03-02 | 2026-02-26 | View filing |
| S-8 | Employee stock plan | 8mo ago2026-02-27 | - | View filing |
| 8-K | Major company event | 8mo ago2026-02-17 | 2026-02-10 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 8mo ago2026-02-13 | - | View filing |
| 4 | Insider trade | 10mo ago2026-01-02 | 2026-01-01 | View filing |
| 3 | New insider ownership | 10mo ago2026-01-02 | 2026-01-01 | View filing |
| 8-K | Major company event | 10mo ago2025-12-17 | 2025-12-16 | View filing |
| 8-K | Major company event | 11mo ago2025-11-21 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 4 | Insider trade | 11mo ago2025-11-19 | 2025-11-17 | View filing |
| 10-Q | Quarterly report | 11mo ago2025-11-14 | 2025-09-30 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-11-14 | - | View filing |
| DEFA14A | Proxy materials | 11mo ago2025-11-12 | - | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-11-04 | - | View filing |
| ARS | Annual report to shareholders | 1y ago2025-10-28 | 2024-12-31 | View filing |
| DEF 14A | Proxy statement | 1y ago2025-10-24 | 2025-11-17 | View filing |
| PRE 14A | PRE 14A | 1y ago2025-10-10 | 2025-11-17 | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-09-19 | - | View filing |
| 10-Q | Quarterly report | 1y ago2025-08-14 | 2025-06-30 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-08-14 | - | View filing |
| 8-K | Major company event | 1y ago2025-07-22 | 2025-07-17 | View filing |
| 8-K | Major company event | 1y ago2025-07-15 | 2025-07-15 | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-15 | 2025-03-31 | View filing |
| 8-K | Major company event | 1y ago2025-05-15 | 2025-05-13 | View filing |
| 424B4 | 424B4 | 1y ago2025-05-14 | - | View filing |
| EFFECT | EFFECT | 1y ago2025-05-13 | - | View filing |
| CORRESP | Company correspondence | 1y ago2025-05-12 | - | View filing |
| CORRESP | Company correspondence | 1y ago2025-05-12 | - | View filing |
| S-1/A | S-1/A | 1y ago2025-05-12 | - | View filing |